News

At NGM, we pride ourselves on conducting world-class science and sharing our research efforts with the broader scientific and medical communities.

Select section

Nov 09, 2015

NGM Bio to Present Data Highlighting the Therapeutic Potential of NGM282 in Cholestatic Liver Diseases at AASLD’s The Liver Meeting® 2015

Read more View PDF

Sep 30, 2015

NGM Bio is named one of FierceBiotech’s “Fierce 15” Biotech Companies of 2015

Read more View PDF

Mar 24, 2015

NGM Biopharmaceuticals Announces Positive Phase 2 Clinical Data in Primary Biliary Cirrhosis Patients for NGM282, a First-in-Class Investigational Medicine

Read more View PDF

Mar 23, 2015

NGM Biopharmaceuticals Secures $57.5 Million Series D Financing

Read more View PDF

Mar 02, 2015

NGM Biopharmaceuticals Announces Expansion of Management Team

Read more View PDF

Feb 23, 2015

NGM and Merck Announce Broad Strategic Collaboration to Discover, Develop and Commercialize Novel Biologic Therapeutics

Read more View PDF